Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has released a Request for Information (RFI) regarding a new initiative to lower prescription drug costs for Medicare recipients.
美國衛生與公共服務部（HHS），通過美國醫療保險和醫療補助服務（康哲藥業），發佈了有關降低藥費的新倡議的信息請求（RFI），以造福於醫保參與者。
The Medicare $2 Drug List Model, developed under President Biden's Executive Order 14087, seeks to offer certain generic drugs for a fixed copayment of no more than $2 per month.
醫療保險2美元藥品清單模型，是在拜登總統的行政令14087號下制定的，旨在爲某些通用藥品提供每月不超過2美元的固定自付款。
This initiative targets commonly prescribed drugs for conditions like high cholesterol and high blood pressure.
此倡議旨在針對常見的高膽固醇和高血壓等病症常開的處方藥。
Also Read: Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets.
此外閱讀：諾和諾德的奧塞康或成2027年醫療保險價格談判目標之一。
The Center for Medicare and Medicaid Innovation (Innovation Center) has designed the Medicare $2 Drug List Model to test whether simplifying access to affordable, clinically important generics will improve health outcomes, improve medication adherence, and boost overall satisfaction with the Medicare Part D program.
醫療保險和醫療補助創新中心（創新中心）設計了醫療保險2美元藥品清單模型，以測試簡化獲取價格實惠、臨床重要的通用藥品是否會提高健康結果，增進藥物依從性，並提升對醫保第D計劃的整體滿意度。
These drugs, which would not be subject to typical utilization management requirements, could be available at all participating pharmacies as early as January 2027.
這些藥物不需要遵守傳統的使用管理要求，最早可以在所有參與藥房提供，且提供時間將是在2027年1月。
The initial list of drugs for the $2 Drug List Model has been carefully developed through a rigorous process. It incorporates input from physicians, pharmacists, and health policy experts to ensure that the selected medications address common conditions for Medicare recipients.
醫療保險2美元藥品清單模型的初始藥品清單經過嚴格的過程精心制定。它採納了醫生、藥劑師和衛生政策專家的意見，以確保選定的藥物能夠解決醫保參與者的常見病症。
The concept of a fixed-cost drug list is not new, with many retail pharmacies already offering generic medications at low, standardized prices.
固定成本藥品清單的概念並不新鮮，許多零售藥店已經以低價標準化的價格提供通用藥品。
However, the Medicare $2 Drug List Model will be tailored specifically to Medicare recipients.
然而，康哲藥業2美元藥品目錄模式將專門針對醫療保險受益人定製。
Last week, the HHS released final guidance for the second Medicare Drug Price Negotiation Program cycle.
上週，衛生與公共服務部發布了第二輪醫療保險藥品價格談判計劃的最終指導方針。
This initiative aims to provide lower drug prices starting in 2026 and 2027.
這項倡議旨在從2026年和2027年開始提供更低的藥品價格。
The first round of negotiations focused on ten specific drugs. When the new prices take effect in 2026, Medicare recipients should save approximately $1.5 billion in out-of-pocket costs.
第一輪談判主要集中在十種特定藥品上。當新價格於2026年生效時，醫療保險受益人應該能夠節省大約15億美元的個人費用。
- Is The iPhone Losing Its Buzz Among Teens? Piper Sandler Finds Out
- 青少年中的iPhone是否正在失去吸引力？派傑投資正在調查
Image via Shutterstock
圖片來自shutterstock。
譯文內容由第三人軟體翻譯。
